Literature DB >> 12536241

Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line.

Angel García-Lora1, Marisol Martinez, Susana Pedrinaci, Federico Garrido.   

Abstract

The activation of natural killer (NK) cells and induction of cytotoxicity are complex processes whose molecular mechanisms have not been clearly elucidated. Stimulation of the NKL human NK cell line with interleukin-2 (IL-2) or protein-bound polysaccharide K (PSK) leads to sustained growth and cytolytic activity in comparison to unstimulated NKL cells. Our previous results shown that IL-2 and PSK regulate different nuclear transcription factors in NKL cells, and that the signal transduction pathway used by these inducers is different. To determine the molecular basis for the different action of IL-2 and PSK, we investigated the upstream effects generated in human NKL cells by IL-2 and PSK on protein kinase C (PKC) isoenzymes and mitogen-activated protein kinases (MAPK). Here we report the profile of unstimulated NKL cells as: PKCbeta>PKCalpha>PKCdelta =PKCepsilon. The PKCeta form was not expressed. The effects of PSK and IL-2 on these isoenzymes were different. IL-2 increased the expression of PKCalpha, PKCdelta and PKCepsilon, whereas PSK decreased the expression of PKCalpha, and also increased PKCdelta and PKCepsilon to higher levels than did IL-2. In MAPK expression we found that unstimulated NKL cells have the following profile: ERK2>ERK6>p38gamma>p38beta>ERK1. ERK3, ERK3 rel, ERK5/ERK4 and p38delta were not expressed. IL-2 decreased the expression of ERK2, whereas PSK did not, and both agents increased the expression of ERK3. These results shown that PSK and IL-2 produce different variations in PKC isoenzymes and MAPK in NKL cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12536241     DOI: 10.1007/s00262-002-0336-9

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  10 in total

Review 1.  Possible mechanisms of action of mushroom-derived glucans on inflammatory bowel disease and associated cancer.

Authors:  Betty Schwartz; Yitzhak Hadar
Journal:  Ann Transl Med       Date:  2014-02

Review 2.  Natural killer cell lines in tumor immunotherapy.

Authors:  Min Cheng; Jian Zhang; Wen Jiang; Yongyan Chen; Zhigang Tian
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 3.  The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies.

Authors:  Christina L Grek; Danyelle M Townsend; Kenneth D Tew
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

Review 4.  Trametes versicolor mushroom immune therapy in breast cancer.

Authors:  Leanna J Standish; Cynthia A Wenner; Erin S Sweet; Carly Bridge; Ana Nelson; Mark Martzen; Jeffrey Novack; Carolyn Torkelson
Journal:  J Soc Integr Oncol       Date:  2008

Review 5.  NK cell-based immunotherapy for malignant diseases.

Authors:  Min Cheng; Yongyan Chen; Weihua Xiao; Rui Sun; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

Review 6.  Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®)): review of development and future perspectives.

Authors:  Yoshihiko Maehara; Shunichi Tsujitani; Hiroshi Saeki; Eiji Oki; Keiji Yoshinaga; Yasunori Emi; Masaru Morita; Shunji Kohnoe; Yoshihiro Kakeji; Tokujiro Yano; Hideo Baba
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

7.  The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis.

Authors:  Eva Jiménez-Medina; Enrique Berruguilla; Irene Romero; Ignacio Algarra; Antonia Collado; Federico Garrido; Angel Garcia-Lora
Journal:  BMC Cancer       Date:  2008-03-24       Impact factor: 4.430

Review 8.  Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future.

Authors:  Khawaja Muhammad Imran Bashir; Jae-Suk Choi
Journal:  Int J Mol Sci       Date:  2017-09-05       Impact factor: 5.923

Review 9.  Therapeutic Potential of Natural Killer Cells in Gastric Cancer.

Authors:  Yu Du; Yongchang Wei
Journal:  Front Immunol       Date:  2019-01-21       Impact factor: 7.561

10.  Differential expression of proteins in naïve and IL-2 stimulated primary human NK cells identified by global proteomic analysis.

Authors:  Weifeng Cao; Arvinder Kapur; Di Ma; Mildred Felder; Cameron O Scarlett; Manish S Patankar; Lingjun Li
Journal:  J Proteomics       Date:  2013-06-25       Impact factor: 4.044

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.